Pfizer Inc
NYSE: PFE
$26.74
+$0.03 (+0.1%)
Closing Price on December 24, 2024
PFE Articles
The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school season.
Published:
Last Updated:
Caterpillar, Apple, Pfizer, and Cisco were Friday's top-gaining Dow stocks.
Published:
Last Updated:
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
Published:
Last Updated:
Merrill Lynch now recommends these five outstanding dividend-paying U.S. stocks with solid upside potential.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The Dow is set to finish essentially flat Wednesday, with Disney and Caterpillar weighing on the index as Pfizer and McDonald's do the heavy lifting.
Published:
Last Updated:
Disney, DowDuPont, Pfizer, and Cisco Systems led the Dow higher Monday.
Published:
Last Updated:
IBM, Pfizer, Walmart, and Coca-Cola were among the leading gainers on the Dow index Friday.
Published:
Last Updated:
3M, Pfizer, Caterpillar, and United Technologies posted the best gains among the Dow 30 stocks Tuesday.
Published:
Last Updated:
Pfizer released better-than-expected second-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Pfizer is scheduled to release its second-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Apple, Pfizer and other Dow companies scheduled to report their quarterly results this week.
Published:
Last Updated:
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in patients with osteoarthritis pain.
Published:
Last Updated:
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated: